title: Inhibition of voltage-gated K+ channel gene expression by the neuropeptide thyrotropin-releasing hormone.
abstract: Many neurotransmitters regulate action potential activity in neuronal, endocrine, and cardiac cells by rapidly modulating the gating of K+ channels. Neurotransmitters might also produce prolonged effects on excitability by regulating the expression of K+ channel genes. Here we show that the neuropeptide thyrotropin-releasing hormone (TRH) down-regulates Kv1.5 and Kv2.1 K+ channel mRNAs in clonal pituitary cells. The effect on Kv1.5 mRNA expression does not require protein synthesis and is due to decreased transcription. Immunoblots demonstrate that Kv1.5 and Kv2.1 immunoreactivities are significantly reduced by TRH within 12 hr. The change in channel protein expression is associated with a decrease in voltage-gated K+ currents. Thus, TRH enhances excitability by inhibiting K+ channel gene expression. Neuropeptide regulation of K+ channel gene expression may produce long-term changes in neuronal action potential activity and synaptic transmission.
authors: Department of Pharmacology, University of Pittsburgh, Pennsylvania 15261.
authors: K
authors: K
authors: Takimoto
authors: R
authors: R
authors: Gealy
authors: A F
authors: AF
authors: Fomina
authors: J S
authors: JS
authors: Trimmer
authors: E S
authors: ES
authors: Levitan
mesh_terms: D015220:Calcium Channels / Q000235:genetics; D002999:Clone Cells; D004594:Electrophysiology; D015870:Gene Expression / Q000187:drug effects*; D015640:Ion Channel Gating; D010902:Pituitary Gland / Q000166:cytology / Q000378:metabolism; D011188:Potassium / Q000502:physiology; D015221:Potassium Channels / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
chemical_list: D015220:Calcium Channels; D015221:Potassium Channels; D012333:RNA, Messenger; D013973:Thyrotropin-Releasing Hormone; D011188:Potassium